Solara Active Pharma Sciences has a quick ratio of 0.60. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Solara Active Pharma Sciences's Quick Ratio or its related term are showing as below:
NSE:SOLARAPP1'
s Quick Ratio Range Over the Past 10 Years
Min: 0.35 Med: 0.57 Max: 0.97
Current: 0.6
During the past 10 years, Solara Active Pharma Sciences's highest Quick Ratio was 0.97. The lowest was 0.35. And the median was 0.57.
NSE:SOLARAPP1's Quick Ratio is ranked worse than 84.95% of 997
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs NSE:SOLARAPP1: 0.60
Solara Active Pharma Sciences (NSE:SOLARAPP1) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Solara Active Pharma Sciences Quick Ratio Related Terms
Solara Active Pharma Sciences Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SOLARAPP1 vs ZTS, UTHR: Quick Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Solara Active Pharma Sciences's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Solara Active Pharma Sciences Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Solara Active Pharma Sciences's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Solara Active Pharma Sciences's Quick Ratio falls into.
Solara Active Pharma Sciences Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a Quick Ratio of 0.60 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Solara Active Pharma Sciences and its competitors. This is near median its historical median of 0.57. Over the past decade, Solara Active Pharma Sciences' Quick Ratio has ranged from 0.35 to 0.97. According to the industry distribution chart, Solara Active Pharma Sciences ranks #847 out of 997 companies in the Drug Manufacturers industry, placing it in the top 85%.
Is Solara Active Pharma Sciences' Quick Ratio too high?
Solara Active Pharma Sciences' current Quick Ratio of 0.60 is near median its 10-year median of 0.57. Over the past 10 years, this metric has ranged from a low of 0.35 to a high of 0.97. The Drug Manufacturers industry median Quick Ratio is 1.45. Solara Active Pharma Sciences' value of 0.60 is 58.6% below this industry median. Based on the distribution chart, Solara Active Pharma Sciences ranks #847 out of 997 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Solara Active Pharma Sciences has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Solara Active Pharma Sciences' Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Solara Active Pharma Sciences ranks #847 out of 997 companies for Quick Ratio. This places Solara Active Pharma Sciences in the lower half of its industry. The industry median Quick Ratio is 1.45. Solara Active Pharma Sciences' value of 0.60 is 58.6% below this benchmark. Historically, Solara Active Pharma Sciences' own Quick Ratio has ranged from 0.35 to 0.97 over the past decade. While the company's 10-year median is 0.57 vs. the industry median of 1.45, Solara Active Pharma Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Solara Active Pharma Sciences's current Quick Ratio of 0.60 is 58.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Solara Active Pharma Sciences and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Solara Active Pharma Sciences's current Quick Ratio is 0.60, which is near median its own 10-year median of 0.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solara Active Pharma Sciences stock overvalued right now?
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a current Quick Ratio of 0.60. The stock's GF Value™ is ₹261.61, compared to a current price of ₹267.45 — trading 2.2% above its estimated fair value. The current Quick Ratio is 0.60, which is near median its 10-year median of 0.57 and 58.6% below the Drug Manufacturers industry median of 1.45. Solara Active Pharma Sciences' overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Solara Active Pharma Sciences (NSE:SOLARAPP1), the current Quick Ratio is 0.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Solara Active Pharma Sciences (NSE:SOLARAPP1) Overvalued in 2026?
Based on GuruFocus' analysis, Solara Active Pharma Sciences stock appears to be overvalued.
The current stock price of ₹267.45 is trading 2.2% above its estimated GF Value™ of ₹261.61.
Key valuation signals for NSE:SOLARAPP1:
Quick Ratio: 0.60 (near median its 10-year median of 0.57)
GF Value™: ₹261.61 vs. price of ₹267.45 (2.2% above fair value)
Industry Position: 58.6% below the Drug Manufacturers median (#847 of 997)
No single metric tells the full story. See the NSE:SOLARAPP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Solara Active Pharma Sciences Business Description
Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.
68GF Score
Get the complete analysis for NSE:SOLARAPP1
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SOLARAPP1 has been successfully added to your 
